A review of herbal and pharmaceutical galactagogues for breast-feeding

Ochsner Journal

Volumn 16, Issue 4, 2016, Pages 511-524

  Bazzano, Alessandra N ^a   Hofer, Rebecca ^a   Thibeau, Shelley ^b   Gillispie, Veronica ^c,d   Jacobs, Marni ^a   Theall, Katherine P ^a  

^a TULANE UNIVERSITY   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c Ochsner Baptist Medical Center   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast feeding; Galactogogues; Health policy; Lactation

Indexed keywords

DOMPERIDONE; GALACTOGOGUE; GARLIC EXTRACT; HERBACEOUS AGENT; METOCLOPRAMIDE; NATALAC; PLACEBO; PLANT MEDICINAL PRODUCT; PROLACTA; SILYMARIN; UNCLASSIFIED DRUG;

BREAST FEEDING; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; EVIDENCE BASED MEDICINE; FENUGREEK; GARLIC; HUMAN; MILK PRODUCTION; MORINGA OLEIFERA; REVIEW; SYSTEMATIC REVIEW; TERMINALIA CATAPPA;

EID: 85006340048     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Horta BL, Victora CG. Long-Term Effects of Breastfeeding: A Systematic Review. Geneva, Switzerland: World Health Organization; 2013. http://apps.who.int/iris/bitstream/10665/ 79198/1/9789241505307_eng.pdf?ua=1. Accessed August 11, 2015.
2. Horta BL, Victora CG. Short-Term Effects of Breastfeeding: A Systematic Review on the Benefits of Breastfeeding on Diarrhoea and Pneumonia Mortality. Geneva, Switzerland: World Health Organization; 2013. http://apps.who.int/iris/bitstream/10665/ 95585/1/9789241506120_eng.pdf?ua=1. Accessed August 11, 2015.
3. World Health Organization. Protecting, Promoting and Supporting Breast-feeding: The Special Role of Maternity Services. A Joint WHO/UNICEF Statement. Geneva, Switzerland: World Health Organization; 1989.
4. American College of Obstetrics and Gynecology. Breastfeeding in Underserved Women: Increasing Initiation and Continuation of Breastfeeding. Committee Opinion No 570. Washington, DC: American College of Obstetrics and Gynecology; 2013.
5. National Center for Chronic Disease Prevention and Health Promotion. Breastfeeding Report Card: United States/2014. Atlanta, GA: Centers for Disease Control and Prevention; 2014. http://www.cdc.gov/breastfeeding/pdf/ 2014breastfeedingreportcard.pdf. Accessed August 11, 2015.
6. World Health Organization. Essential Nutrition Actions: Improving Maternal, Newborn, Infant and Young Child Health and Nutrition. Geneva, Switzerland: World Health Organization; 2013. http://apps.who.int/iris/bitstream/10665/84409/1/ 9789241505550_eng.pdf. Accessed August 11, 2015.
7. Division of Child Health and Development. Evidence for the Ten Steps to Successful Breastfeeding. Geneva, Switzerland: World Health Organization; 1998. http://apps.who.int/iris/bitstream/ 10665/43633/1/9241591544_eng.pdf. Accessed August 11, 2015.
8. Neifert MR. Prevention of breastfeeding tragedies. Pediatr Clin North Am. 2001 Apr;48(2):273-297.
9. Nice FJ. Selection and use of galactogogues. Infant Child Adoles Nutr. 2015 Aug;7:192-194.
10. Dewey KG, Nommsen-Rivers LA, Heinig MJ, Cohen RJ. Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics. 2003 Sep;112(3 Pt 1):607-619.
11. Chapman DJ, Perez-Escamilla R. Identification of risk factors for delayed onset of lactation. J Am Diet Assoc. 1999 Apr;99(4): 450-454; quiz 455-456.
12. Arbour MW, Kessler JL. Mammary hypoplasia: not every breast can produce sufficient milk. J Midwifery Womens Health. 2013 Jul-Aug;58(4):457-461.
13. Duran MS, Spatz DL. A mother with glandular hypoplasia and a late preterm infant. J Hum Lact. 2011 Nov;27(4):394-397.
14. Mennella JA, Pepino MY, Teff KL. Acute alcohol consumption disrupts the hormonal milieu of lactating women. J Clin Endocrinol Metab. 2005 Apr;90(4):1979-1985.
15. Mennella JA, Pepino MY. Breastfeeding and prolactin levels in lactating women with a family history of alcoholism. Pediatrics. 2010 May;125(5):e1162-e1170.
16. Rasmussen KM, Hilson JA, Kjolhede CL. Obesity may impair lactogenesis II. J Nutr. 2001 Nov;131(11):3009S-3011S.
17. Nommsen-Rivers LA, Chantry CJ, Peerson JM, Cohen RJ, Dewey KG. Delayed onset of lactogenesis among first-time mothers is related to maternal obesity and factors associated with ineffective breastfeeding. Am J Clin Nutr. 2010 Sep;92(3): 574-584.
18. Michel MP, Gremmo-Féger G, Oger E, Sizun J. Pilot study of early breastfeeding difficulties of term newborns: incidence and risk factors [in French]. Arch Pediatr. 2007 May;14(5): 454-460.
19. Davanzo R, Cannioto Z, Ronfani L, Monasta L, Demarini S. Breastfeeding and neonatal weight loss in healthy term infants. J Hum Lact. 2013 Feb;29(1):45-53.
20. Grzeskowiak LE, Lim SW, Thomas AE, Ritchie U, Gordon AL. Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital. J Hum Lact. 2013 Feb;29(1):32-37.
21. Grzeskowiak LE, Dalton JA, Fielder AL. Factors associated with domperidone use as a galactogogue at an Australian tertiary teaching hospital. J Hum Lact. 2015 May;31(2):249-253.
22. Sim TF, Sherriff J, Hattingh HL, Parsons R, Tee LB. The use of herbal medicines during breastfeeding: A population-based survey in Western Australia. BMC Complement Altern Med. 2013 Nov 13;13:317.
23. The Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #9: use of galactogogues in initiating or sugmenting the rate of maternal milk secretion. Breastfeed Med. 2011 Feb;6(1):41-49. http://www.bfmed.org/Media/Files/ Protocols/Protocol%209%20-%20English%201st%20Rev. %20Jan%202011.pdf. Accessed August 12, 2015.
24. Gabay MP. Galactogogues: medications that induce lactation. J Hum Lact. 2002 Aug;18(3):274-279.
25. Lindstrom A, Ooyen C, Lynch ME, Blumenthal M, Kawa K. Sales of herbal dietary supplements increase by 7.9% in 2013, marking a decade of rising sales: turmeric supplements climb to top ranking in natural channel. HerbalGram. 2014;(103):52-56.
26. Sim TF, Hattingh HL, Sherriff J, Tee LB. Perspectives and attitudes of breastfeeding women using herbal galactagogues during breastfeeding: a qualitative study. BMC Complement Altern Med. 2014 Jul 2;14:216.
27. Winterfeld U, Meyer Y, Panchaud A, Elnarrson A. Management of deficient lactation in Switzerland and Canada: a survey of midwives’ current practices. Breastfeed Med. 2012 Aug;7: 317-318.
28. da Silva OP, Knoppert DC, Angelini MM, Forret PA. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. CMAJ. 2001 Jan 9;164(1):17-21.
29. Campbell-Yeo ML, Allen AC, Joseph KS, Ledwidge JM, Allen VM, Dooley KC. Study protocol: a double blind placebo controlled trial examining the effect of domperidone on the composition of breast milk [NCT00308334]. BMC Pregnancy Childbirth. 2006;6:17.
30. Campbell-Yeo ML, Allen AC, Joseph KS, et al. Effect of domperidone on the composition of preterm human breast milk. Pediatrics. 2010 Jan;125(1):e107-e114.
31. Jantarasaengaram S, Sreewapa P. Effects of domperidone on augmentation of lactation following cesarean delivery at full term. Int J Gynaecol Obstet, 2012 Mar:116(3)240-243.
32. Petraglia F, De Leo V, Sardelli S, Pieroni ML, D’Antona M, Genazzani AR. Domperidone in defective and insufficient lactation. Eur J Obstet Gynecol Reprod Biol. 1985;19(5):281-287.
33. de Gezelle H, Ooghe W, Thiery M, Dhont M. Metoclopramide and breast milk. Eur J Obstet Gynecol Reprod Biol. 1983 Apr; 15(1):31-36.
34. Hansen WF, McAndrew S, Harris K, Zimmerman MB. Metoclopramide effect on breastfeeding the preterm infant: a randomized trial. Obstet Gynecol. 2005 Feb;105(2):383-389.
35. Fife S, Gill P, Hopkins M, Angelo C, Boswell S, Nelson KM. Metoclopramide to augment lactation, does it work? A randomized trial. J Matern Fetal Neonatal Med. 2011 Nov;24(11): 1317-1320.
36. Seema, Patwari AK, Satyanarayana L. Relactation: an effective intervention to promote exclusive breastfeeding. J Trop Pediatr. 1997 Aug;43(4):213-216.
37. Sakha K, Behbahan AG. Training for perfect breastfeeding or metoclopramide: which one can promote lactation in nursing mothers? Breastfeed Med. 2008 Jun;3(2):120-123.
38. Lewis PJ, Devenish C, Kahn C. Controlled trial of metoclopramide in the initiation of breast feeding. Br J Clin Pharmacol. 1980 Feb;9(2):217-219.
39. Yabes-Almirante C, Lim CHTN. Effectiveness of Natalac as a galactagogue. J Pak Med Assoc. 1996;71(3):265-272.
40. Sharma S, Ramji S, Kumari S, Bapna JS. Randomized controlled trial of Asparagus racemosus (Shatavari) as a lactogogue in lactational inadequacy. Indian Pediatr. 1996 Aug;33(8):675-677.
41. Gupta M, Shaw B. A double-blind randomized clinical trial for evaluation of galactogogue activity of Asparagus racemosus Willd. Iran J Pharm Res. 2011 Winter;10(1):167-172.
42. Damanik R, Wahlqvist ML, Wattanapenpaiboon N. Lactagogue effects of Torbangun, a Bataknese traditional cuisine. Asia Pac J Clin Nutr. 2006;15(2):267-274.
43. Turkyilmaz C, Onal E, Hirfanoglu IM, et al. The effect of galactagogue herbal tea on breast milk production and shortterm catch-up of birth weight in the first week of life. J Altern Complement Med. 2011 Feb;17(2):139-142.
44. Espinosa-Kuo CL. A randomized-controlled trial on the use of malunggay (Moringa oleifera) for augmentation of the volume of breastmilk among mothers of term infants. Filipino Fam Physician. 2005;43(1):26-33.
45. Di Pierro F, Callegari A, Carotenuto D, Tapla MM. Clinical efficacy, safety and tolerability of BIO-C (micronized Silymarin) as a galactagogue. Acta Biomed. 2008 Dec;79(3):205-210.
46. Mennella JA, Beauchamp GK. The effects of repeated exposure to garlic-flavored milk on the nursling’s behavior. Pediatr Res. 1993 Dec;34(6):805-908.
47. Donovan TJ, Buchanan K. Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants. Cochrane Database Syst Rev. 2012 Mar 14; 3:CD005544. doi:10.1002/14651858.CD005544.pub2.
48. Osadchy A, Moretti ME, Koren G. Effect of domperidone on insufficient lactation in puerperal women: a systematic review and meta-analysis of randomized controlled trials. Obstet Gynecol Int. 2012;2012:642893. doi:10.1155/2012/642893.
49. Ahmad N, Keith-Ferris J, Gooden E, Abell T. Making a case for domperidone in the treatment of gastrointestinal motility disorders. Curr Opin Pharmacol. 2006 Dec;6(6):571-576.
50. Carroccio A, Iacono G, Montalto G, Cavataio F, Soresi M, Notarbartolo M. Domperidone plus magnesium hydroxide and aluminum hydroxide: a valid therapy in children with gastroesophageal reflux. A double-blind randomized study versus placebo. Scand J Gastroenterol. 1994 Apr;29(4):300-304.
51. Bines JE, Quinlan JE, Treves S, Kleinman RE, Winter HS. Efficacy of domperidone in infants and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 1992 May;14(4):400-405.
52. De Loore I, Van Ravensteyn H, Ameryckx L. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. Postgrad Med J. 1979;55(suppl 1):40-42.
53. Cresi F, Marinaccio C, Russo MC, Miniero R, Silvestro L. Shortterm effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring. J Perinatol. 2008 nov;28(11):766-770.
54. Paul C, Zenut M, Dorut A, et al. Use of domperidone as a galactagogue drug: a systematic review of the benefit-risk ratio. J Hum Lact. 2015 Feb;31(1):57-63.
55. Bozzo P, Koren G, Ito S. Health Canada advisory on domperidone: should I avoid prescribing domperidone to women to increase milk production? Can Fam Physician. 2012 Sep;58(9):952-953.
56. US Food and Drug Administration. FDA Talk Paper: FDA warns against women using unapproved drug, domperidone, to increase milk production. June 7, 2004. http://www.fda.gov/ Drugs/DrugSafety/InformationbyDrugClass/ucm173886.htm. Accessed April 27, 2016.
57. Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007;102(9):2036-2045.
58. Wan EW, Davey K, Page-Sharp M, et al. Dose-effect study of domperidone as a galactagogue in preterm mothers with insufficient milk supply, and its transfer into milk. Br J Clin Pharmacol. 2008 Aug;66(2):283-289.
59. Forinash AB, Yancey AM, Barnes KN, Myles TD. The use of galactogogues in the breastfeeding mother. Ann Pharmacother. 2012 Oct;46(10):1392-1404.
60. Betzold CM. Galactagogues. J Midwifery Womens Health. 2004 Mar-Apr;49(2):151-154.
61. Marasco L. Inside track. Increasing your milk supply with galactogogues. J Hum Lact. 2008;24(4):455-456.
62. Royal Pharmaceutical Society. A new mother is having trouble producing breast milk. What options are available to help? Clinical Pharmacist. 2010 Jan;2:260.
63. Shaffer D, Butterfield M, Pamer C, Mackey AC. Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. J Am Pharm Assoc. 2004 Nov-Dec;44(6):661-665.
64. Dahl E, Diskin AL. Long-lasting adverse effects after short-term low-dose treatment with metoclopramide for vomiting. Int Marit Health. 2014;65(1):16-19.
65. Rumore MM, Lee SE, Wang S, Farmer B. Metoclopramideinduced cardiac arrest. Clin Pract. 2011 Nov 2;1(4):e83.
66. Anfinson TJ. Akathisia, panic, agoraphobia, and major depression following brief exposure to metoclopramide. Psychopharmacol Bull. 2002 Winter;36(1):82-93.
67. Surawski RJ, Quinn DK. Metoclopramide and homicidal ideation: a case report and literature review. Psychosomatics. 2011;52(5):403-409.
68. Ingram J, Taylor H, Churchill C, Pike A, Greenwood R. Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial. Arch Dis Child Fetal Neonatal Educ. 2012;97(4):F241-F245.
69. Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Romagnoli C. Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production. J Pharm Pharm Sci. 2010;13(2):162-174.
70. Rasmussen KM, Dieterich CM, Zelek ST, Altabet JT, Kjolhede CL. Interventions to increase the duration of breastfeeding in obese mothers: the Bassett Improving Breastfeeding Study. Breastfeed Med. 2011 Apr;6(2):69-75.
71. Asztalos EV, Campbell-Yeo M, daSilva OP, Kiss A, Knoppert DC, Ito S. Enhancing breast milk production with domperidone in mothers of preterm neonates (EMPOWER trial). BMC Pregnancy Childbirth. 2012 Aug 31;12:87.
72. Mortel M, Mehta SD. Systematic review of the efficacy of herbal galactogogues. J Hum Lact. 2013;29(2):154-162.
73. Nice FJ. Common herbs and foods used as galactogogues. Infant Child Adolesc Nutr. 2011 June;3(3):129-132.
74. King J, Raguindin PF, Dans LF. Moringa oleifera (Malunggay) as a galactagogue for breastfeeding mothers: a systematic review and meta-analysis of randomized controlled trials. Philipp J Pediatr. 2013 Dec;61(2):34-42.
75. Stohs SJ, Hartman MJ. Review of the safety and efficacy of Moringa oleifera. Phytother Res. 2015 Jun;29(6):796-804.
76. Kroll DJ, Shaw HS, Oberlies NH. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther. 2007 Jun;6(2):110-119.
77. American Botanical Council. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines: Part One-Introduction. Austin, TX: American Botanical Council; 1999. http://cms.herbalgram.org/commissione/intro/comm_e_int. html. Accessed April 27, 2016.
78. Food and Drug Administration. Dietary Supplement Products & Ingredients. http://www.fda.gov/Food/DietarySupplements/ ProductsIngredients/default.htm. Accessed August 21, 2016.
79. Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013 Feb;13(1):7-12.
80. Schaffir J, Czapla C. Survey of lactation instructors on folk traditions in breastfeeding. Breastfeed Med. 2012 Aug;7: 230-233.
81. Jensen R. Fenugreek: overlooked but not forgotten. UCLA Lact Alumni Newsletter. 1992(1):2-3.Breastfeeding Online. http:// www.breastfeedingonline.com/fenugreekoverlooked. shtml#sthash.c0c9BUGE.dpbs. Accessed April 27, 2016.